Assembly Biosciences (ASMB) on Friday announced the pricing of an underwritten, registered offering consisting of close to 5.6 million common shares and pre-funded warrants to purchase about 1.04 million common shares.
It added that the offering also includes Class A and Class B warrants to acquire up to 6.6 million common shares, priced at a combined $19.60 per common share with accompanying warrants, and $19.599 per pre-funded warrant with accompanying warrants.
The company also said Gilead Sciences will purchase close to 2.3 million shares of common stock and accompanying Class A warrants and Class B in a private placement at a similar price of $19.60 per share.
Assembly Biosciences shares were up 8.2% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.